The Transthyretin Amyloid Cardiomyopathy Treatment Market is poised to increase with focus on developing next generation gene silencing therapies
by Market Overview Transthyretin amyloid cardiomyopathy (ATTR-CM) or familial amyloid cardiomyopathy is a rare but fatal progressive heart condition caused due to mutation in the transthyretin …